Skip to content

IR Contact

INVESTOR RELATIONS AND CORPORATE COMMUNICATIONS

Temre Johnson
Investor Relations and Corporate Communications
Mirati Therapeutics
858-332-3562
ir@mirati.com
 

Please submit your question using the form below.

* Indicates required field